Get email alerts on the Opioid Settlements topic
No spam. Unsubscribe anytime.
O’Brien County approves three resolutions to join opioid settlement agreements
Summary
The Board approved three resolutions authorizing O’Brien County to enter settlement agreements with multiple opioid manufacturers and distributors, including a Sandoz settlement and settlements involving several secondary manufacturers and multiple Purdue-related entities.
The O’Brien County Board of Supervisors voted Sept. 23 to approve three resolutions authorizing the county to enter settlement agreements related to opioid litigation. Resolution No. 2025-33 authorizes agreements with Sandoz; Resolution No. 2025-34 approves settlements with listed secondary manufacturers (Alvogen Inc.; Apotex Corp.; Amneal Pharmaceuticals LLC; Hikma Pharmaceuticals USA Inc.; Indivior Inc.; Viatris Inc. (Mylan); Sun Pharmaceutical Industries, Inc.; Zydus Pharmaceuticals (USA) Inc.); and Resolution No. 2025-35 approves settlement agreements with numerous Purdue-related entities and affiliates as enumerated in the minutes.
Each resolution was moved and carried by all ayes, per the minutes; the record does not show individual vote tallies or settlement amounts in the board minutes. The resolutions authorize O’Brien County’s participation in the county-level settlement framework against certain manufacturers, distributors and retailers of opioid pharmaceuticals and instruct county officials to finalize agreements according to the adopted resolutions.
AI generated
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
